Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) EBT (2017 - 2025)

Selectis Health's EBT history spans 14 years, with the latest figure at -$502660.0 for Q3 2025.

  • For Q3 2025, EBT rose 69.41% year-over-year to -$502660.0; the TTM value through Sep 2025 reached -$2.6 million, up 67.52%, while the annual FY2024 figure was -$4.8 million, 57.1% up from the prior year.
  • EBT for Q3 2025 was -$502660.0 at Selectis Health, up from -$676280.0 in the prior quarter.
  • Across five years, EBT topped out at $987560.0 in Q2 2022 and bottomed at -$3.7 million in Q4 2023.
  • The 5-year median for EBT is -$1.3 million (2024), against an average of -$1.3 million.
  • The largest annual shift saw EBT tumbled 1451.62% in 2021 before it skyrocketed 252.37% in 2022.
  • A 5-year view of EBT shows it stood at -$2.0 million in 2021, then dropped by 12.4% to -$2.2 million in 2022, then tumbled by 65.07% to -$3.7 million in 2023, then surged by 87.67% to -$452978.0 in 2024, then fell by 10.97% to -$502660.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's EBT are -$502660.0 (Q3 2025), -$676280.0 (Q2 2025), and -$964413.0 (Q1 2025).